4.6 Article

Pain experiences among those living with hidradenitis suppurativa: a qualitative study

Journal

BRITISH JOURNAL OF DERMATOLOGY
Volume 188, Issue 1, Pages 41-51

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/bjd/ljac018

Keywords

-

Categories

Ask authors/readers for more resources

This qualitative study interviewed 21 adults with HS-related pain to understand their pain experiences. Pain affected various aspects of their lives and many participants managed their pain without medical guidance. Asking HS patients about their pain can help identify unmet needs, improve pain management, and enhance quality of life.
In this qualitative study, we interviewed 21 adults with HS-related pain to characterize their lived pain experiences. Pain impacted many quality of life (QoL) domains, yet participants often treated their pain without guidance from medical providers. Asking HS patients about pain may identify unmet pain needs, facilitate pain management, and improve QoL. Background Pain is rated by patients with hidradenitis suppurativa (HS) as the disease's most impactful symptom. HS therapies are often insufficient to control inflammatory disease activity and pain. A better understanding of patient experiences with pain may improve patient-provider relationships and help identify strategies for addressing HS pain. Objectives This qualitative study sought to characterize lived pain experiences of those with HS. Methods English-speaking patients >= 18 years old with a dermatologist-confirmed diagnosis of HS and an average numerical rating scale pain score of >= 1 over the preceding week were recruited from a single academic medical centre in Atlanta, Georgia, USA. Semistructured interviews were conducted from November 2019 to March 2020 to explore participants' HS pain experiences and the subsequent impact on their lives. Thematic saturation was reached after interviewing 21 participants. Interviews were audio recorded, transcribed, and analysed using thematic analysis. Results Among 21 study participants, the median 7-day average pain score was 6 (interquartile range 3-7; scale ranges from 0 to 10, with 10 being most pain). Participants' descriptions of pain were consistent with nociceptive pain, neuropathic pain and itch. Pain impacted multiple life domains, including physical limitations (decreased mobility and impaired sleep), decreased psychological wellbeing (irritability, depression, loss of control, and difficulty communicating pain experiences) and impaired social relationships (social isolation, intimacy problems and difficulty fulfilling social responsibilities). Although participants reported chronic discomfort, acutely painful and unpredictable HS disease flares caused more distress and quality-of-life (QoL) burden. Participants frequently treated their pain without input from the medical team, sometimes with unsafe medication doses or combinations. Factors contributing to self-management of pain included difficulty accessing timely outpatient care during disease flares and fear of stigma from healthcare providers. Conclusions When present, HS-related pain may impact not only physical wellbeing but also mental health and relationships. In addition to therapies that target the inflammatory disease burden, treating the symptom of pain may improve patients' QoL and wellbeing. Because patients with HS have difficulty explaining their pain, proactively asking them about pain may identify unmet needs, facilitate better pain control and improve QoL. Further, the influence of HS-related pain on numerous aspects of QoL suggests the need for multidisciplinary, patient-centred approaches to HS pain management.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available